Le Lézard
Classified in: Health
Subjects: PDT, IMA

Sysmex Receives Health Canada Clearance Paving the Way for Complete Clinical Flow Cytometry Solution


MISSISSAUGA, ON, May 16, 2024 /CNW/ -- Sysmex, a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology, has received a Medical Device License for the XF-1600tm Flow Cytometer, paving the way for a complete clinical flow cytometry solution in Canada.

The complete clinical flow cytometry solution features the fully automated PS-10tm Sample Preparation System, a Helmer UltraCW® II Automatic Cell Washing System, and flow cytometry with the stable, reliable XF-1600 Flow Cytometer.

For research applications requiring detailed analysis, VenturiOne® flow cytometry software is also available with the XF-1600.

Throughout the entire process from preparation to analysis, samples remain in rotors that are moved between each module, virtually eliminating potential errors. In addition to sample preparation, the PS-10 is designed to prepare reagent cocktails with Sysmex's portfolio of high-quality antibodies, for optimal clinical laboratory performance. Highly trained operators no longer have to spend hours manually pipetting, leaving valuable time for more complex activities.

"This approval allows Sysmex America to meet the growing needs of customers in Canada," said Andy Hay, chief executive officer of Sysmex America. "Laboratories and medical institutions will have access to this complete clinical flow cytometry solution that offers robust data collection with seamless integration, aiding in the accurate and timely identification of diseases and improving patient outcomes."

To learn more about Sysmex flow cytometry products, visit www.sysmex.com/flowcytometryca.

About Sysmex America
The combination of Sysmex America's new testing methods and innovative hematology, urinalysis, information systems and flow cytometry testing technology are transforming the future of healthcare and contributing to healthier lives. As Americas regional affiliate of Kobe, Japan-based Sysmex Corporation ? a trusted global leader respected for optimizing the efficiency, operations and financial performance of clinical laboratories ? it offers diagnostic products that equip patients and the healthcare professionals who treat them with the information needed to make decisions with greater trust and confidence. Forbes magazine named Sysmex one of the most innovative companies in the healthcare equipment and services category, and the Center for Companies That Care named Sysmex America to its "Honor Roll." Learn more about Sysmex America at www.sysmex.com/us.

SOURCE Sysmex America, Inc.


These press releases may also interest you

at 12:07
The Women in Insurance Cancer Crusade (WICC) took another step closer to its goal of raising $25 million by 2025 at their annual Relay for Life fundraising event, held on June 6th . Nearly 300 people came together for an evening of camaraderie for...

at 12:00
"I wanted to create a simple and attractive way to secure your glasses to your shirt, jacket or other article of clothing," said an inventor, from Port St. Lucie, Fla., "so I invented the EYEGLASS PIN HOLDER. My design enables you to keep your...

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...

at 11:32
The American Parkinson Disease Association (APDA) is celebrating the President's signing of the National Plan to End Parkinson's Act yesterday, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson's...

at 11:30
NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico received a regulatory approval letter from the ethical, scientific, and safety committees of Hospital La Mision in Monterrey, Mexico, to launch a clinical...

at 11:00
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....



News published on and distributed by: